ERBB2 and adenocarcinoma: We initially focused on examining the two CSC pairs, BC1 and BC2 cells, because they are thought to be represented of stage IV adenocarcinomas with BC1 being estrogen and progesterone receptor positive and Her2/neulow and BC2 being negative for estrogen and progesterone receptor and as well as Her2/neu (i.e., triple negative).